Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma

JCI Insight(2025)10.1172/jci.insight.187073Source: DataRank Database

Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma is a research paper published in JCI Insight (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.70)OA: goldTopics (40)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Trey E Gilpin,Apoorva T. Patil ORCID,Emily Chiu,R. W. R. Baker ORCID,Peng Liu ORCID

Live enrichment

PubMed:40168074 OpenAlex:https://openalex.org/W4409045812

National Institutes of Health

Grant: R01 DK068634

National Institutes of Health

Grant: P30 CA014520

National Institutes of Health

Grant: S10 OD023526

National Institutes of Health

Grant: K08 DK127244

National Institutes of Health

Grant: T32 HL007899

NCATS NIH HHS

Grant: UL1 TR000114

NCI NIH HHS

Grant: R50 CA278811

FWCI

0.70

Citation Percentile

0.7%

Citation Trend

2026

goldLicense: cc-by

journalhttp://insight.jci.org/articles/view/187073/files/pdf

publisherhttp://insight.jci.org/articles/view/187073/files/pdf

publisherhttps://insight.jci.org/articles/view/187073/files/pdf

journalhttps://doi.org/10.1172/jci.insight.187073

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40168074

Fields of Study

Metastasis and carcinoma case studiesCongenital heart defects researchRNA modifications and cancerHumansFemaleGATA2 Transcription FactorUterine NeoplasmsNeoplasm Recurrence, LocalMiddle AgedRetrospective StudiesCystadenocarcinoma, SerousAgedNeoplasm InvasivenessPrognosisBiomarkers, Tumor

MeSH Terms

AgedFemaleHumansMiddle AgedNeoplasm InvasivenessNeoplasm Recurrence, LocalPrognosisRetrospective StudiesBiomarkers, TumorUterine NeoplasmsCystadenocarcinoma, SerousGATA2 Transcription Factor

Keywords

MedicineCarcinomaSerous fluidCancerInternal medicineOncologySerous carcinomaUterine cancerCancer researchOvarian cancerClinical ResearchObstetrics/gynecologyTumor suppressors

Sustainable Development Goals

SDG 0: Good health and well-being